1 / 51

OBSTRUCTIVE SLEEP-RELATED BREATHING DISORDERS IN ADULTS

OBSTRUCTIVE SLEEP-RELATED BREATHING DISORDERS IN ADULTS. DR. MOHSEN PAZOOKI. Obstructive sleep-related breathing disorders. Snoring Upper Airway Resistant Syndrome Obstructive Sleep Apnea Syndrome. Snoring. Incidence 40% M 20% F

snow
Download Presentation

OBSTRUCTIVE SLEEP-RELATED BREATHING DISORDERS IN ADULTS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. OBSTRUCTIVE SLEEP-RELATED BREATHING DISORDERS IN ADULTS DR. MOHSEN PAZOOKI

  2. Obstructive sleep-related breathing disorders • Snoring • Upper Airway Resistant Syndrome • Obstructive Sleep Apnea Syndrome

  3. Snoring • Incidence • 40% M • 20% F • Often (but not always) accompanies sleep disordered breathing • Not ass. With excessive daytime sleepiness or insomnia

  4. Snoring • AHI < 5 without daytime symptoms • PSG is not required for Dx • No ass. With : • Arousals • Desaturations • Airflow limitation • Arrhythmias

  5. Upper airway resistant syndrome • Do not meet OSA criteria but experience excessive daytime somnolence and other debilitating somatic complaints

  6. Upper airway resistant syndrome • characterized by respiratory effort related arousals (RERAs) • RERA is detected using esophageal pressure manometry, which reveals a pattern of progressively increasing negative esophageal pressure followed by an arousal.

  7. Upper airway resistant syndrome • PSG : • Frequent arousals associated with snoring, abnormally negative intrathoracic pressure, or increased diaphragmatic electromyogram activity.

  8. OSAS • Incident : • 2% of F & 4% of M > 50y

  9. OSAS • five or more respiratory events (apneas, hypopneas, or RERAs) • Ass. with • excessive daytime somnolence, • Waking with gasping, choking, or brearh-holding, or • witnessed reports of apneas, loud snoring, or both

  10. OSAS • apnea or hypopnea commonly accompanied by: • Reductions in blood oxygen saturation of at least 3% to 4% • Usually terminated by brief, unconscious arousals

  11. OSAS • Snoring: • frequent complaint of bed partners • often the symptom that prompts these patients to seek medical attention • Excessive daytime somnolence : common presenting complaint

  12. OSAS • Other complaints : • Automobile accidents • increased cardiovascular morbidity and mortality • morning headache, sore throat • fatigue or a feeling of being unrefreshed regardless of the duration of sleep

  13. OSAS • Exacerbation : • ingestion of alcohol • Sedative use • weight gain

  14. Sleep disordered breathing symp • Restless sleep • Loud snoring • Observed apnea,choking or gasping episodes • Excessive daytime sleepiness(E DS) • Morning fatigue or irritability • Memory loss • Decreased cognitive function

  15. Sleep disordered breathing symp • Depression • Personality or mood changes • Decreased libido and impotence • Morning and nocturnal headaches • Nocturnal sweating • Nocturnal enuresis

  16. Pathophysiology • collapse of the pharyngeal airway during sleep due to relaxation of the pharyngeal dilator muscles

  17. Obesity • soft tissue hypertrophy • craniofacial characteristics such as retrognathia

  18. Major areas of obstruction • Nose • Palate • Hypopharynx • laryngeal obstruction from bilateral laryngeal paralysis, laryngomalacia, and obstructing laryngeal lesions has also been reported.

  19. Obesity • major risk factor for OSA • deleterious effects on metabolism, ventilation, and lung volume, resulting in V/Q mismatch • Significantly reduce lung volume, which results in a reduction of functional residual capacity

  20. Adenotonsillar hypertrophy : major cause in children • In adults : multiple craniofacial variations

  21. Consequences of untreated OSAS • increased mortality • increase in cardiovascular disease: • hypertension, coronary heart disease, congestive heart failure, arrhythmias, sudden death, pulmonary hypertension, and stroke • neurocognitive difficulties • increased risk of motor vehicle accidents by 2.5-fold

  22. Consequences of untreated OSAS • independent risk factor for insulin resistance • contribute to the development of diabetes and metabolic syndrome,theterm used to describe the commonly occurring conditions of obesity, insulin resistance, hypertension, and dyslipidemia.

  23. Consequences of untreated OSAS • GERD : (Treatment with CPAP decreases the occurrence of GERD) • problems with attention, working memory, and executive function (all of which are improved with CPAP treatment)

  24. Diagnosis • most common symptoms : • loud snoring • restless sleep • daytime hypersomnolence

  25. Diagnosis • Obesity :70% of adult patients • Screening, including a detailed sleep history and physical examination, is recommended for all obese patients

  26. Epworth Sleepiness Scale

  27. Epworth Sleepiness Scale • OSA may be suspected in patients with an ESS greater than 10

  28. Dx • patients with HTN, CAD, CHF, CVA, and DM, must be carefully screened for the signs and symptoms of OSA • Women : insomnia, heart palpitation, ankle edema

  29. P.E. • P.E. strengthens the Dx • BMI , BP , Neck circumference

  30. Dx • Fiberoptic Flexible Nasopharyngoscopy (with Muller’s Maneuver) • Drug induced sleep videoendoscopy • Nocturnal PSG : gold standard

  31. Sleep related breathing disorders

  32. Sleep related breathing disorders

  33. Medical Tx. • a stepwise manner begins with conservative medical measures. • 'Weight loss” for all overweight patients • Consultation with a bariatric surgeon in morbidly obese patients • surgically induced weight loss significantly improves obesity-related OSA and parameters of sleep quality as early as 1 month after surgery.

  34. Medical Tx. • CPAP : gold standard for moderate to severe OSAS • Reduction in AHI, sleepiness, CVA, motor vehicle accidents & improvement in QOL • Decreased inflammation as measured by a decrease in the inflammatory markers CRP and IL-6, improved endothelial function, and reduced diurnal sympathetic activity.

  35. Medical Tx. • BiPAP • APAP • Oral appliances for mild, moderate OSA (greater satisfaction) • Pharmacologic therapy: alternative in CPAP intolerance: Modafinil, Fluticazone, Montelukast, nasal dilator strips, topical decongestants

  36. Indications of Surgical Tx.

  37. Sx. options

  38. Sx. options

  39. Sx. options

More Related